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Research Article 
INTRODUCTION 
The most important Gram-positive human pathogens, 
such as Staphylococcus aureus, Streptococcus pneu-
moniae and Enterococci remain as public health men-
ace (Woodford and Livermore, 2009). The major health
-care concern is due to the emergence of resistant 
strains such as methicillin-resistant Staphylococcus 
aureus (Cornaglia, 2009) and vancomycin-resistant 
enterococci (VRE) strains (Eades et al., 2017). In de-
veloping countries, factors such as poor drug quality, 
improper drug dosage, the high rate of self-medication 
(Ayukekbong et al.,2017), unhygienic conditions, con-
taminated food, and water supply, poor domestic and 
animal contact attributed to the development of drug-
resistant strains (O'Neill 2015, Grace, 2015). According 
to a research, four main factors are responsible for mi-
crobial resistance such as (i) noncompliance (ii) incor-
Abstract 
Gram-positive bacteria cause various diseases from the superficial skin to deep tissue infections. The capability of causing nu-
merous diseases is due to the production of virulence factors which are tightly regulated by the virulence genes. Various Gram-
positive pathogenic bacteria e.g. Staphylococcus, Mycobacterium, and Listeria are capable of causing lethal infections in hu-
mans and animals. Conventional antibiotics, targeted antibiotics, and combinatorial drugs are used as therapeutic agents 
against Gram-positive pathogens. Due to intricate virulence pathway bacteria readily adopt resistance to available drugs. There-
fore, there is need to develop some alternative approaches to combat these infections. Various natural extracts are effective 
against pathogenic bacteria with or without the available drugs. Curcumin is a natural extract of Curcuma longas rhizome, 
known as turmeric. Curcumin shows various biological activities such as antimicrobial, antioxidant and anti-inflammatory. It also 
shows strong antibacterial activity against Gram-positive and few Gram-negative bacteria. Besides all these beneficial applica-
tions, major drawbacks of curcumin are poor aqueous solubility and less bioavailability. However, drug delivery approaches 
including nanoformulation are developed to increase its stability in vitro and in vivo settings. The present review article focused 
on the translation of potential applications of curcumin in various diseases specifically caused by Gram-positive pathogens. 
Various methods used for the formulations of curcumin nanoparticles, combinatorial strategies with curcumin nanoparticles and 
their application in the prevention of infections have been discussed. The present article also discusses the future aspects of 
curcumin-nanoparticles and its use as an alternative therapeutic approach against pathogens. 
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rect use of broad-spectrum agents (iii) incorrect dosing 
and (iv) excess antibiotic usage (Niederman, 2005). 
The genetic material alteration also leads to the for-
mation of resistant strains by mutation, and it can be an 
innate, intrinsic, or acquired type (Mihaescu et al., 
2007, Decoster et al., 2008). Several Gram-positive 
pathogens are responsible for various diseases such as 
skin and soft tissue infections, wound infections, urinary 
infections, gastrointestinal infections, osteomyelitis, 
endocarditis, pneumonia, thrombophlebitis, inflamma-
tion of breast tissue (mastitis), inflammation of the brain 
and spinal cord surrounded membrane (meningitis), 
toxic shock syndrome and septicemia (Nair et al., 
2014). An antimicrobial substance that kills or inhibits 
bacterial growth is called antibiotics (Himaniand  Joshi, 
2019). Various traditional herbs can inhibit the growth of 
Gram-positive and Gram-negative bacteria and now 
these medicinal herbs are used for the treatment of 
microbial infections (Evans et al., 2002). These herbs 
include Azadirachtaindica (neem), Curcuma longa 
(turmeric), Acacia nilotica L. (Babul), Withania somnif-
era (Ashwagandha) (Dhamaet al., 2014). In this review 
article, we have focused on the therapeutic properties 
and applications of curcumin, which is an active compo-
nent of turmeric. 
Curcumin is a polyphenolic flavonoid compound ob-
tained by rhizome of turmeric (Curcuma longa L.) (Mun 
et al., 2014). Diferuloylmethane or curcumin is a major 
phytochemical component of turmeric (Zingiberaceae 
family), which is responsible for giving the yellow colour 
to the herb. Curcumin extracted from turmeric by vari-
ous methods of solvent extraction e.g., Soxhlet, ultra-
sonic, microwave, and supercritical carbon dioxide, fol-
lowed by purification via column chromatography (Li et 
al.,2014, Priyadarsini, 2014). For many years, curcumin 
has been used as a pharmaceutical agent because of 
its antioxidant, anti-inflammatory, anti-carcinogenic, and 
antimicrobial properties (Epstein et al., 2010; Naksuriya 
et al., 2014). It has also wound healing and anti-ageing 
activities (Akbik et al., 2014; Lima et al., 2011). Curcu-
min also shows beneficial effects to control blood glu-
cose levels and enhanced mucosal gastric secretion in 
rabbits (Arun and Nalini, 2002). In 1815, curcumin mol-
ecules were isolated the first time and in 1873, Rough-
ley and Whiting had given its chemical structure (Rai et 
al., 2015), in 1873. In 2014, Priyadarsini reported the 
chemical formula of curcumin as C21H20O6 with a mo-
lecular weight of 368.38 gm/mole. Turmeric contains 
approximately 77% diferuloylmethane (curcumin I), 
17% Demethoxycurcumin (curcumin II), and 6% bisde-
methoxycurcumin (curcumin III) components (Fig. 1) 
(Aggarwal et al., 2007). Curcumin is hydrophobic in 
nature contains two polyphenolic rings, which consist of 
o-methoxy phenolic groups, and curcumin shows tau-
tomerization in a pH-dependent condition (Beevers and 
Huang, 2011). 
FUNCTIONAL ASPECTS AND APPLICATIONS OF 
CURCUMIN 
Antimicrobial activity 
Naturally occurring substances especially from plants 
have great potential for controlling food spoilage and 
infections caused by pathogens. Curcuma is a natural 
plant product obtained from Curcuma longa widely 
used in medical application (Salehi et al., 2019). Upen-
dra and his co-workers found that turmeric at a concen-
tration of 0.8 and 1.0g/L showed significant antifungal 
activity in plant tissue culture (Upendra et al., 2011). 
Methanol extracted curcumin obtained by the turmeric 
used against Cryptococcus neoformans and Candida 
albicans, showed antifungal activity with MIC 128μg/mL 
and 256 μg/mL. Ungphaiboon et al., demonstrated anti-
fungal activity of hexane extracted curcumin against 
Rhizobium solani, Erysiphe graminis, and Phytophthora 
infestans (Ungphaiboon et al., 2005). Curcumin blocks 
membrane-associated ATPase activity and reduces the 
secretion of proteinase (Martins et al., 2009). Recently, 
Hu et al., reported that curcumin act on endoplasmic 
reticulum and minimize the effect of in Cryptococcus  
neoformans infection (encapsulated yeast) (Hu et al., 
2017).  Sometime Antiviral therapeutics are still in the 
nest and there is a lack of effective therapeutic thera-
pies, high cost of antiviral therapies and to overcome 
the chemical side effects, it compels to investigate the 
properties of naturally occurring compounds such as a 
component of green tea (Steinmann et al., 2013), cin-
namon (Connell et al., 2016), and various types of 
herbs against viral infections. Curcumin is a pleiotropic 
molecule with great potency to show antiviral activity 
against different kind of viruses e.g., hepatitis viruses, 
influenza viruses, chikungunya virus (CHIKV) or arbo-
viruses, human immunodeficiency virus (HIV), human 
papillomavirus (HPV), herpes simplex virus 2 (HSV-2) 
and also effective against sexually transmitted diseases 
(Praditya et al., 2019). Gopal and his coworkers com-
pared the bactericidal activity of three types of curcu-
min particles e.g., macro, micro, and nano against 
Escherichia coli, Salmonella enteritidis12021, Strepto-
coccus mutans11823, and Staphylococcus aureus. The 
results showed that the bactericidal activity of curcumin 
nanoparticles was enhanced compared to macro and 
micro curcumin particles (Gopal et. al., 2016). In a 
study found that curcumin decorated micelles particles 
increase the antibacterial activity of miltefosine and 
alkyl phosphocholines erufosine toward S. aureus path-
ogenic strain (Zaharieva et al., 2019).  It has been 
found that curcumin (MIC 125 to 250 μg/mL) was  
effective against 10 strains of S. aureus (e.g., two 
ATCC MRSA, and MRSA standard strains, four MRSA 
from culture collection and four MRSA clinical isolates) 
(Mun et al., 2013). Curcumin with MIC 256 μg/mL also 
effective against MSSA (methicillin-susceptible Staphy-
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lococcus aureus) (Wang et al., 2016). When curcumin 
is used in combination with antibiotics such as cefaclor, 
penicillin, gentamicin, erythromycin, and amikacin, it 
shows synergistic antibacterial activity (Teow et al., 
2016). To understand the curcumin antibacterial activity 
some researchers demonstrated that curcumin has the 
potential to interfere with FtsZ (FtsZ homolog in eukary-
otes is cytoskeletal tubulin protein) in vitro and stops 
the FtsZ ring (Protofilament) assembly in Bacillus sub-
tilis, and observed that curcumin inhibits the bacterial 
cell proliferation by stopping the assembly of FtsZ 
mechanism (Rai et al., 2008).Therefore, FtsZ is the 
novel component of bacteria, which can be a drug tar-
get for the development of antimicrobial agents against 
S. aureusatsui et al., 2012; Singh and Panda, 2010). 
Mun et al.,had shown that in the periplasm of Gram-
negative and cell surface of Gram-positive bacteria 
ATP-binding cassette (ABC) transporters are located. 
ATP-dependent transporting activity of ABC transport-
ers was inhibited by the curcumin in combination with 
ATPase inhibitors such as N, N-
dicyclohexylcarbodiimide (DCCD), NaN3 by inhibiting 
the H+ translocation activity and stops the growth of S. 
aureus MRSA (Mun et al., 2014) and also noted that 
penicillin-binding protein (PBP) or PBP2 encoded by 
the mecAgene in S. aureus MRSA stabilizes the cell 
wall formation and showed resistant towards β-lactam 
antibiotics by blocking the interaction between β-lactam 
and penicillin-binding protein (PBP)(Fig. 2) (Mun et al., 
2014). However, a combination of β-lactam antibiotics 
with curcumin inhibits Mec A gene synthesis in MRSA 
and enhances the activity of antibiotics (Mun et al., 
2014). It is reported that polymeric micelles coated sil-
ver particles with curcumin molecules were very effec-
tive against Staphylococcus aureus and P. aeruginosa 
(Huang et al., 2017). In chicken and mice curcumin 
was effective in kidney and liver injury caused by afla-
toxin induction (Verma et al., 2008; Zhang et al., 2016) 
and minimized the effect of oxidative stress (mediated 
by aflatoxins) (Wang et al., 2018). Furthermore, the 
formulation of curcumin loaded PLGA nanoparticles 
improved the activity of curcumin; PLGA is hydrolyzed 
into lactic acid and glycolic acid and eliminated outside 
the cell in the form of H2O and CO2 with the help of the 
Krebs cycle (Lu et al., 2009). 
Anti-biofilm activity 
Curcumin inhibits the quorum sensing and acts as an 
inhibitor of biofilm formation (Deryabin et al., 2019). 
Pseudomonas aeruginosa secreted exopolysaccha-
rides polymer substances e.g., imipenem and amino-
glycosides, which enhanced biofilm formation. Curcu-
min's anti-biofilm activity against two Pseudomonas 
aeruginosa strains obtained by cystic fibrosis suffering 
patients were observed with MIC: 16 μg/m through the 
crystal violet staining method (Karaman et al., 2013). It 
is found that curcumin inhibits the expression of biofilm 
inducing gene (31 quorum sensing (QS) genes) reduc-
ing virulence factors such as acyl-homoserine lactone 
(HSL) secretion, pyrocyanin biosynthesis, and activity 
of protease (Rudrappa and Bais, 2008). In S. mutans, 
UA159 curcumin could reduce biofilm activity and pre-
vent the maturation of biofilm by exopolysaccharide 
reduction (Li et al., 2018). 
Anti-protozoan activity 
Ethanol extraction of turmeric (rhizome) has anti-
Entamoeba histolytica activity. It also shows anti-
Leishmania activity in vitro conditions (Koide et al., 
2002). Curcumin synthetic derivatives have anti-
Leishmania, amazonensis activities (Gomes et al., 
2002). Rasmussen et al., reported that curcumin also 
inhibits the activity of Plasmodium falciparum 
(Rasmussen et al., 2000).  
Antioxidant activity 
Curcumin has excellent antioxidant activity (Alsamydai 
and Jaber, 2018). Harmful chemicals, trauma, auto-
immune disorders, and infections can be responsible 
Fig. 1. (a) Structure of Diferuloylmethane (Curcumin I) (b) 
Structure of Demethoxycurcumin (Curcumin II) (c) Struc-
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for the production of free radicals in the body, curcumin 
has capacity to protect the cells from free radicals and 
work as a scavenger for reactive oxygen species 
(Akram et al., 2010). Curcumin is a bioactive compo-
nent of turmeric (Kotha and Luthria, 2019), turmeric's 
water-and-fat-soluble extracts show potent antioxi-
dant activity like vitamin C, vitamin E, and β-
carotene (Akram et al., 2010). Curcumin significantly 
inhibits the peroxidation of lipids in various animal 
models (Maheshwari et al., 2006). Metabolism of 
lipoxygenase (LOX), arachidonic acid, and cyclooxy-
genase (COX) inhibited by the curcumin, which al-
ters the productions of steroidal hormones 
(Mosovska et al., 2016). Researchers have investi-
gated the antioxidant property of curcumin in animal 
cells by exposing the oxygen and nitrogen-free radi-
cal species and concluded the antioxidant efficacy of 
curcumin (Rafiee et al., 2019). 
Anti-inflammatory activity 
A secondary metabolite of curcumin and its volatile oils 
show great anti-inflammatory activity, 100mg/kg of eth-
anol extracted turmeric component is significantly ad-
ministered to male rats in the granuloma pouch model 
and showed great activity against inflammation. In in-
duced pedal edema doses of 200mg/kg, 400 mg/kg, 
and 800 mg/kg were active in carrageen. However, 
turmeric extract showed no activity in the granuloma 
pouch model when reducing the dose to 50.0 mg/kg 
(Bhat et al., 2015). Several studies have reported that 
curcumin inactivates the process of inflammation 
through various mechanism (Khalil and Mustafa, 
2020; Mohammed and Mustafa, 2020).  In the case of 
acute inflammation, oral curcumin was more effective 
compared to phenylbutazone or cortisone and re-
duced inflammatory swelling in rats with Freund's ad-
juvant-induced arthritis. Curcumin is also effective in 
neutrophil aggregation related to inflammation, in 
monkeys, at the time of inflammation, it inhibits the 
biosynthesis of inflammatory prostaglandins and ara-
chidonic acid (Akram et al., 2010). Curcumin Nano-
micelle particles had more anti-inflammatory efficacy 
to inhibit paraquat (PQ) responsible for lung injury 
(Hosseini et al., 2019).  
Fig. 2. Diagrammatic representation of various mode of actions of PLGA curcumin nanoparticles against Gram positive 
pathogens (a) Curcumin inhibits protofilament  assembly and cytokinesis (Rai et al., 2008) (b) Curcumin increase sensi-
tivity towards  β-lactam antibiotic (Mun et al., 2014) (c) Curcumin interact between NAG and NAM, causes cell lysis (Mun 
et al., 2014, Tyagi et al., 2015)  (d) Gylcolic acid  and Lactic acid  eliminate outside the cell in the form of CO2 + H2O (Lu 
et al., 2009).  
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Anti-carcinogenic activity 
Curcumin exhibits anti-carcinogenic properties which 
act as a panacea for the treatment of various types of 
cancers in human curcumin inhibits tumor growth and 
proliferation of cells; it is also capable of suppressing 
the mutagens and carcinogen's activity in different 
types of cells (in vitro and in vivo) (Akram et al., 2010). 
Curcumin molecule alter the activity of NF-kB factors 
responsible for the activation of gene related to prolifer-
ation, antiapoptotic and invasion (Tan and Norhaizan, 
2019). Due to antioxidant and free-radical engulfing 
properties, curcumin shows anti-carcinogenic activity. It 
indirectly increases the level of glutathione that helps in 
liver detoxification from harmful carcinogens and muta-
gens as well as stops the synthesis of nitrosamine 
(Akram et al., 2010). Curcumin is a very potent agent 
for controlling and regulating the metabolic activation 
and detoxification of harmful mutagens and carcino-
gens. Curcumin inhibits the action of cytochrome P450 
and this enzyme stimulates the action of carcinogens 
and mutagen (Duvoix et al., 2005).  In lung and breast 
cell lines PLGA curcumin nanoparticles reduced the 
expression of NF-kB and HIF-1α in the hypoxic tumor 
microenvironment (Khan et al., 2018). Curcumin en-
hances metabolizing enzymes and antioxidant activity 
(Igbal et al., 2003). Curcuminoid exhibits several im-
munomodulatory effects (Churchill et al., 2000), sup-
presses the production of superoxide (free radicals) by 
macrophages and also enhances phagocytic activity of 
macrophages observed in the curcumin-treated animal 
model (Lukita-Atmadja et al., 2002). 
TARGETED VS. COMBINATIONAL DRUG THERAPY 
AGAINST GRAM-POSITIVE PATHOGENS 
Instead of broad-spectrum antibiotics, narrow-spectrum 
antibiotics, or targeted antibiotics that are specific for 
particular pathogenic bacteria either Gram-positive or 
Gram-negative provides an efficient approach to treat 
specific resistant pathogens with a less toxic effect on 
the gut microbiome (Maxson and Mitchell, 2016). Differ-
ent types of synthetic targeted antibiotic therapies are 
available against Gram-positive pathogens such as 
Linezolid, Vancomycin, Teicoplanin, Daptomycin, 
Tigecycline, and Ceftaroline (Guillamet and Kollef, 
2014). Over the targeted antibiotic therapy, combina-
tional drug therapy is an appropriate method for treat-
ing multidrug-resistant (MDR) bacteria. Three main 
mechanisms of antibiotic resistance are described by 
Walsh in 2000: (i) enzymatic breakdown of β-lactam 
antibiotics with the help of β-lactamases enzymes and 
phosphorylation or acetylation, adenylation of amino-
glycosides (ii) Antibiotic removal from the bacterial cell, 
through the efflux membrane-bound protein, efflux 
membrane proteins force out the drug molecules faster 
than its diffusion hence, decreasing the overall intracel-
lular concentration of antibiotics required to exert the 
antibiotic effect (iii) Modification of penicillin- binding 
protein (PBP2a) by the bacteria, PBPs have a lower 
affinity to β-lactam antibiotics resulted in continuous cell 
wall synthesis (Worthington and Melander,  2013). In 
combined drug therapy pairing is done between antibi-
otic- antibiotic or antibiotic with a non-antibiotic mole-
cule. The combinations of two drugs have a synergistic 
effect, enhanced killing rate, and increased dosage 
response in in vivo settings (Bhardwaj et al., 2016). 
Researchers have found that combined drug therapy of 
curcumin and chemotherapeutics have pharmaceutical 
activity and also reported their mode of action in vitro 
and in vivo (Redondo-Blanco et al. 2017). The naturally 
occurring substance used for combination therapy with 
antibiotics is the most beneficial approach for MDR 
bacteria. Combinational effect of curcumin with various 
antibiotics on S. aureus by disk diffusion method and 
found that curcumin increased the antibacterial activi-
ties of antibiotics cefotaxime, cefixime, tetracycline, and 
vancomycin against S. aureus. Although cefixime 
showed the maximum fold increases in the area (52.6% 
fold increase) against test strain (Worthington and Me-
lander, 2013). In combinational drug therapy, the inter-
action of two antimicrobial agents is an important factor 
for the formulation hence, at the time of drug develop-
ment this factor must be taken into consideration 
(Moghaddam et al., 2009). Zhang et al., 2020 reported 
efficacy of chemotherapy medicine and various plant 
extract such as xanthohumol, curcumin, genistein, pro-
anthocyanidins, mangiferin, luteolin, quercetin, garcinol, 
and furanodiene against breast cancer and their mech-
anisms in vivo and in vitro condition. Combinational 
drug therapy is the most powerful tool for the treatment 
of various critical diseases like HIV (Richman, 2001), 
cancer, and antibiotic-resistant infections (Lane 2006, 
Mitchison and Davies 2012, Fischbach 2011).  In a 
study reported that when paclitaxel combined with cur-
cumin greatly stimulate apoptosis process and antipro-
liferative in MCF-7 and MDA-MB231 (human breast cell 
lines) (Calaf et al., 2018; Kang et al., 2009; Quispe et 
al., 2016; Zhan et al., 2014). Combined effect of natural 
plant products have more potential to fight against 
breast cancer cells as compare to single plant extract 
(Kapinova et al. 2017; Koh and Pan 2018). Combina-
tional drug therapy is an alternative approach for the 
treatment of multi and extremely drug-resistant bacteri-
al infections.  
 
THERAPEUTIC APPLICATIONS OF NANO-
PARTCLES  
Nanoparticles are used in different areas successfully 
due to their high volume-surface ratio and quantum 
effects; these factors change the nanoparticle proper-
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ties such as electrical behavior, reactivity, strength, and 
in vivo nature. Nanoparticles have been used to devel-
op much cheaper, effective, and quicker treatments 
against pathogens (Duggal, 2011). Previous studies 
have demonstrated that nanoparticles such as Ag-NPs, 
TiO2-NPs, and ZnO-NPs (used for sewage treatment) 
may show the toxic effect on aquatic organisms 
(Gottschalk et al., 2009), while gold, silver, and copper 
nanoparticles have the great anticancer potential (Jain 
et. al., 2012, Jannathul and Lalitha 2015, Sanpui et. al., 
2011). Gold nanoparticles showed optical and catalytic 
properties which makes it unique due to its biocompati-
ble and nontoxic in nature and used in various fields 
(Nambiar et al., 2018). Anticancer and antidiabetic ac-
tivities of ZnO-NP have been reported by a group 
(Umrani and Paknikar 2014, Taccola et al., 2011). CUR
-SF (curcumin silk fibroin) nanoparticles are effective 
and stable drug delivery agent and exhibit anticancer 
effect against intestinal colon cancer than native curcu-
min (Xie et al., 2017). The anti-cancer activity may in-
volve in DNA repair, cell proliferation, cell differentia-
tion, angiogenesis, progression and carcinogen metab-
olism (Rejhova et al., 2018; Singh et al., 2016). Green 
synthesis of metal nanoparticles has shown beneficial 
effects due to their less toxicity, cheap and eco-friendly 
properties compare to other chemical methods 
(Makarov et al., 2014), synthesis of nanoparticles by 
the microorganisms have been reported as environ-
mental-friendly alternatives over physical and chemical 
methods (Makarov et al., 2014). Green synthesis of 
gold nanoparticles (AuNP's-Cur) observed in HCT-
116 and MCF-7 (breast cancer cell lines). Results 
suggested that AuNP's-Cur effectively reduce apop-
totic and proliferation effect in cancer cells compared 
to curcumin molecule (Elbialy et al., 2019). Similarly, 
it was suggested that MNP-PEG-Cur nanoparticles 
(magnetic nanoparticle ornamented with PEGylated 
curcumin) were good biocompatible drug delivery 
agent for antitumor drugs (Ayubi et al., 2019). Nam-
biar et al., 2018 reported that gold nanoparticles for-
mulated together with the plant products had diverse 
applications in biomedical fields. Polymeric nanoparti-
cles are made up of a long number of repeating units 
(macromolecules) and arrange in a series showing 
unique properties and structure, which is useful in 
biomedical applications (Jain, 2008). Nanoparticles 
can be successfully used in targeted drug delivery at 
the site of infection to improve (Duggal, 2011): bioa-
vailability of the drug, successful uptake of less solu-
ble drugs, and targeting of the drug at an appropriate 
site. Duggal, also reported that nanoparticles possess 
various kinds of advantages: Enhanced bioavailability 
potential, reduced toxicity, small amount requirement, 
and increased surface area of the active agent 
(Duggal, 2011). Besides metal nanoparticles, polymer-
based nanospheres have been made which possess 
several advantages such as easy to synthesize, cost-
effective, biocompatible, biodegradable, nontoxic, solu-
ble in water, non-immunogenic (Bolhassani et al., 
2014). 
Polymeric nanoparticles that are classified (in vivo) as 
biodegradable are Poly-glycolide (PGA) (Park et al., 
2009), Poly (L-lactide) (PLA) (Mainardes et. al., 2010) 
and non-biodegradable like polyurethane (Fritzen-
Garcia et al., 2009). PEG-albumin-curcumin (PAC) na-
noparticles exhibits greater anticancer activity against 
breast cancer cell line due to more bioavailability and 
long-time stability in blood circulation (Thadakapally et 
al., 2016). Characteristics of nanoparticles like strength, 
performance, flexibility, chemical, and physical behav-
iour advocate their use in pharmaceutical industries 
and medicine such as: in drug delivery, tumour detec-
tion as well as visual monitoring of therapy (Gwinn and 
Vallyathan, 2006). Different types of nanoparticles and 
their roles are described in Table 1. 
FORMULATION OF CURCUMIN NANOPARTICLES 
The studies from the last three decades showed that 
curcumin exhibits poor absorption, reduced bioavaila-
bility, poor metabolism, elimination, and rapid degrada-
tion (Krausz et al., 2015). Therefore, to overcome these 
problems, it is necessary to design an advanced drug 
delivery system that can enhance the therapeutic trans-
lation of curcumin. Chauhan et al., 2014 reported differ-
ent drug delivery systems like liposome (formulation of 
curcumin for parenteral administration). Liposome ex-
hibits several properties like high stability, better solu-
bility, high biocompatibility and easy preparation 
(Moballegh Nasery et al., 2020), nanoparticles 
(polymeric and solid lipid NPs), and microemulsion 
(Bansal et al., 2011, Maiti et al., 2007). Polymeric nano-
particles have features like biocompatible, small in size 
and stay in bloodstream for longer time (Ferrari et al., 
2018). Roacho-Perez et al., 2020 reported that magnet-
ic nanoparticles are of low synthesis cost and highly 
responsive for cancer treatments. Curcumin-
nanoparticles are probably the most effective approach 
for the therapeutic application of curcumin. In this re-
view, we have focused on the formulations of curcumin 
loaded poly (lactic-co-glycolic) acid (PLGA) nanoparti-
cles and its efficacy against different types of human 
pathogens. There are several methods for the synthe-
sis of curcumin loaded PLGA nanoparticles (PLGA-cur-
NPs). We have discussed all the methods, including 
the positive and negative aspects of techniques used 
as below: 
Coacervation method 
In this method, the polymer is dissolved in ethyl ace-
tate, dichloromethane, or acetonitrile (organic solvent) 
and curcumin molecules directly suspended within the 
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polymeric solution and then leave it to homogenize. 
High-speed centrifugation is employed for Nanoparti-
cles collection. The disadvantage of this method is that 
it requires more solvent (Dhivya and Rajalakshmi, 
2018). 
Single emulsion method 
Curcumin NPs are synthesized by dispersing it in a 
solvent, by ultrasonication or high-speed homogeniza-
tion to form the emulsion. The solvent evaporated from 
the emulsion by continuous magnetic stirring under 
reduced pressure at room temperature. After this, step 
the emulsion is ultrasonicated then collected, washed 
(distilled H2O) to remove additives and allow to lyophi-
lized to create nanoparticles. Curcumin loaded PLGA 
nanoparticles can also be prepared by the Single emul-
sion method (Dhivya and Rajalakshmi 2018). 
Solvent evaporation method 
Two steps involve in the Solvent Evaporation Method 
(i) Solution of drug-polymer preparation step (ii) dis-
persing solvent evaporation, and this step helps curcu-




Antimicrobial, antiviral activity and 
used in textile industries, water treatment,  and 
sunscreen lotions etc. 
Rai, Yadav and Gade, 2009, Shar-
ma, Ria and Lin, 2009 
Gold 
Used in the identification of protein interactions, 
detect cancer stem cells, beneficial for cancer 
diagnosis, and  identification of different classes 
of bacteria. 
Baban and Seymour, 1998, Tomar 
and Garg, 2013 
Magnet 
Fe3O4 (Magnetite) and Fe2O3 (maghemite)  both 
are biocompatible NPs, used in manipulation, 
stem cell sorting, guided drug delivery system, 
magnetic resonance imaging (MRI), gene thera-
py, and DNA analysis. 
Fan, Chow and Zhang, 2009 
Copper 
Copper NPs are DNA-cleavage agents, efficient 
anticancer, and modifiable surface properties by 
conjugation with various biomolecules including 
proteins and enzymes. 
Fang et al., 2010,  Thanh and 
Green, 2010, Wang et al., 2015, 
An  and Zhang 2017. 
Polyethylenimine (PEI) 
PEI (cationic polymer) used for nucleic acid deliv-
ery, immune dysfunction, cancers and allergy. 
Saengkrit et al., 2012, Nguyen and 
Friedman, 2013 
Poly- £- caprolactone (PCL) 
PCL is used for the development of contraceptive 
devices, wound dressings, drug delivery systems 
as well as fixation devices. 
Bilensoy et al., 2009 
Polyacrylate 
Antibiotic-conjugated Polyacrylate nanoparticles 
are used as antimicrobial agents. 
Turos et al., 2007 
A-----lbumin 
 This is used for the delivery of protein, oligonu-
cleotides, DNA as well as drugs. 
Moreno-Vega et al., 2012, Bolhas-
sani et al., 2014 
Heparin 
Used for the delivery of oligonucleotides, DNA, 
protein, and drugs. 
Moreno-Vega et al., 2012,  Bolhas-
sani et al., 2014 
Chitosan Used as a carrier of DNA for gene delivery.  Nguyen et al., 2009 
Poly(lactic- co-glycolic acid) 
(PLGA) 
Used as drug release devices, implants to repair 
fractures, and surgical sutures. 
Xiaoling and Haskara 2006, Steva-
novic and Skokovic 2009, Steva-
novic et al., 2008. 
Table 1. Various compounds used for the formation of nanoparticles and their diverse role and applications. 
 
117 
Sankhwar, R. et al. / J. Appl. & Nat. Sci. 13(1): 110 - 126 (2021) 
min to dissolve properly. Formation of emulsion that 
changed into nanoparticle suspension followed by a 
solvent evaporation process. The advantages and dis-
advantages of this method are: (i) for evaporation of 
solvent required low temperature (ii) prevention of ther-
mal deposition can occur. (i) difficulty in the selection of 
solvent (ii) it is a time-consuming process due to evap-
oration of the organic solvent (iii) in this method expen-
sive reagents used. PLGA (Poly (lactic acid-co-glycolic 
acid) curcumin nanoparticles can be formulated by this 
method (Dhivya and Rajalakshmi 2018). 
Solvent displacement method 
This method, also called the Nanoprecipitation method, 
within a suitable solvent a particular polymer is sus-
pended which results in the formation of a polymeric 
solution. Add natural drug-like curcumin into it. A drug-
polymer combination solution is poured into the H2O by 
stirring it without interruption after some time gets pre-
cipitation. Then left solvent for evaporation by hot air-
flow. Formation of nano-drugs in the amorphous state 
by the spray drying method may lead to partial crystalli-
zation. In this, polymer and curcumin are dissolved in 
the same mixture of solvents (Dhivya and Rajalakshmi 
2018). 
Solvent evaporation method (Solid-in-oil-in-water 
emulsion; s/o/w) 
In this method, PLGA dissolved in chloroform (organic 
solution) as an oil phase. Free curcumin is added to the 
PLGA or chloroform solution and after this emulsion is 
added to a solution of ethanol and PVA (Polyvinyl alco-
hol) and sonicated. For removing the organic phase 
(evaporation) of solvent (chloroform) s/o/w emulsion 
agitated by stirrer. The sample is then centrifuged and 
washed three times with distilled water. After this, sam-
ple is freeze-dried for 24 hrs to obtain nanoparticle dry 
powder. The nanoparticles are stored at 4 0C for further 
use (Mukerjee and Vishwantha 2009, Nair et al., 2012). 
Single emulsion-solvent evaporation method 
This method is suitable for loading curcumin (a hydro-
phobic compound) in hydrophilic solvent, PLGA-
curcumin nanoparticles can be formed (Cartiera et al., 
2010). In the desired amount of ethyl acetate, PLGA 
polymer dissolved into it after this step drug (curcumin) 
added to this mixture and for left 30 minutes for com-
plete dissolution (intermittent vortexing). Then Poly 
(vinyl alcohol) (PVA) is mixed in H2O that act as a sur-
factant after this step mixture of curcumin PLGA added 
into it drop-wise with intermittent vortexing. The mixture 
is sonicated to create a fine emulsion. Then this emul-
sion is added to PVA in H2O and stirred rapidly with a 
magnetic stirrer for about 3 hours. PVA helps in stabi-
lizing the emulsion and small particles with uniform size 
are formed. The nanoparticles are collected by centrifu-
gation and washed three times with Milli-Q distilled wa-
ter. Then at 4 0C freeze-dried nanoparticles are stored 
(Mathew et al., 2012). 
Double-emulsion or single-emulsion with vitamin  
e-tpgs 
Recently Rebecca et al., used vitamin E-D-β-
Tocopherol polyethylene glycol succinate (TPGS) as 
the emulsifying agent. The major advantage of using 
TPGS is that it improves emulsification and encapsula-
tion efficiency compared to other emulsifying agents. In 
a test tube, 100 mg PLGA, and 1 ml of dichloro-
methane (DCM) or ethyl acetate (EtAc) solvent added 
in it. Then, 2 ml of 0.3 vitamins E-TPGS is added to the 
glass test tube. For hydrophobic substances: encapsul-
ant added to the polymer solution directly, then vortex 
the test tube until encapsulant is homogenously spread 
over a wide area (dispersed). For hydrophilic sub-
stances: the polymer solution with emulsify encapsul-
ant added before starting the addition of drug in buffer 
or H2O to the polymeric solution. For emulsification, 
the polymer and the drug combination ultrasonicated 
for some time. The polymer solution directly dropped 
onto the surface of the emulsifier with continuous vor-
texing. Immediately, the emulsified polymer is ultra-
sonicated that forms the nanoparticles in the precipi-
tation, and allow the solvent to evaporate (McCall and 
Sirianni, 2013).  
APPLICATION OF PLGA-CURCUMIN NANO 
PARTICLES  
Curcumin is a pleiotropic phytonutrient exhibit number 
of therapeutic properties, but their optimum potential is 
hindered by poor solubility, low oral bioavailability, in-
sufficient water solubility leading to low absorption and 
rapid degradation. To overcome these drawbacks nano 
vehicles like the drug delivery system were investigated 
such as curcumin loaded PLGA (polylactide- co-
glycolide) nanoparticles for its better activity and bioa-
vailability for cellular absorption (Anand et al., 2010). A 
study showed that curcumin obtained by the heat ex-
traction method increases the solubility of curcumin 12-
fold without any degradation (Kurien et al., 2007). Simi-
larly, nanoformulation enhance the therapeutic and 
biological applications of curcumin molecules 
(Karthikeyan et al., 2020). Another study found that 
curcumin nanoparticles size ranges between 2- 40 nm 
prepared by the wet-milling technique have a small 
size, large surface area, and increased bioavailability. 
These curcumin NPs are more easily dispersed in wa-
ter as compared to the curcumin without any formula-
tion and show more effective antimicrobial activity 
against Escherichia coli, Bacillus subtilis, Staphylococ-
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cus aureus, Pseudomonas aeruginosa, and two known 
pathogenic fungi Penicillium notatum and Aspergillus 
niger (Bhawana et al., 2011, Shailendiran et al., 2011). 
Recently, it was reported that PLGA curcumin nanopar-
ticles suppress the NF-kB signaling in mammary glands 
infected by Staphylococcus aureus. Thus, curcumin 
nanoparticles are also beneficial for murine mastitis 
(Suresh et al., 2018). Curcumin stability can be en-
hanced by the micro-encapsulation method which im-
proves the bioavailability and solubility of curcumin and 
also shows antimicrobial activity against various food-
borne pathogens (MIC ranges between 15.7μg/mL to 
250μg/mL), e.g. Escherichia coli, Staphylococcus aure-
us, Bacillus subtilis, Yersinia enterocolitica and Penicil-
lium notatam. This suggests that microencapsulated 
curcumin particles can be used as a food preservative 
and colourant in food industries (Wang et al., 2009, 
Wang et al., 2012). 
In the present time, one of the most useful applications 
of curcumin loaded PLGA nanoparticles are in the 
treatment of different types of human cancer (Mukerjee 
and Vishwantha, 2009), which is less toxic due to their 
degradative nature compare to other drugs (Dauda et 
al., 2017). All these studies suggest that the broad-
spectrum activity of this golden spice (turmeric) is suc-
cessfully enhanced by curcumin loaded PLGA nano-
particles. Curcumin is a hydrophobic molecule that pos-
sesses miracle biological activities. Poly (lactic-co-
glycolic acid) is one of the most important bio-
degradable and bioabsorbable polymer which is elimi-
nated by the body itself (Stevanovicet al., 2009). The 
PLGA polymers are also used as surgical sutures, frac-
ture repair, and medical devices (Xiaoling and Haskara, 
2006). PLGA has ester linkages that give hydrolysis 
reaction in water and forms two monomers glycolic acid 
and lactic acid which are metabolized and eliminated 
through the Kreb's cycle as H2O+ CO2 (Fig. 3) (Lu et 
al., 2009). 
A variety of antibiotics are used for the treatment as 
well as prevention of bacterial infections but due to im-
proper use of antibiotics, the emergence of multi-drug 
resistant strain is a big challenge (Ayukekbong 
Ntemgwa and Atabe, 2017). Naturally occurring mole-
cules have an excellent opportunity for the develop-
ment of new therapeutic, which can be effective against 
various resistant pathogens. Curcumin is a natural 
compound extracted from turmeric rhizome, it is hydro-
phobic, and a pleiotropic molecule that gives the yellow 
color to the turmeric and exhibits different types of ther-
apeutic activities (Allam, 2009, Magalhaes et al., 2009). 
Fig. 3. Representation of formation of PLGA curcumin nanoparticles and its fate within the living cells (Lu et al., 2009). 
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Several antimicrobial activities of curcumin have been 
reported by a group of scientists (Bhawana et al., 2011; 
Tongnuanchan and Benjakul, 2014) and demonstrated 
that the turmeric component stopped the activity of S. 
aureus and E. coli. The methanolic extract of turmeric 
exhibited strong antimicrobial activity (Alcaraz et al., 
2000, Niamsa and Sittiwet, 2009). Curcumin also 
shows anti-inflammatory, wound-healing, hypoglyce-
mic, and antioxidant properties as well as induce apop-
tosis in different types of cells (Aggarwal, Sung 2009, 
Akram et al., 2010). Moreover, curcumin has several 
types of therapeutic activities like anticancer and have 
great potency to reduce the proliferation of cells, me-
tastasis of tumor cells, and transformation(Nakamura  
et al., 2002, Shishodia et al., 2007). Curcumin also 
shows the good chemoprotective agent in cancer thera-
py(Duvoix et al., 2005). Anti-MRSA activity of curcumin 
sensitizing methicillin-resistant Stayphylococcus aure-
us (MRSA) against various antibiotics (Mun et al., 
2014). Instead of this, curcumin has a property to cure 
different eye-related problems like inflammation of the 
eye, red eye condition, pain, and loss of vision. Re-
search has shown that curcumin was effective against 
uveitis disease when 600 mg dose was orally given to 
the 106 patients twice a day for 12 to 18 months. After 
a treatment within a few weeks, more than 80% of the 
patients were relieved from eye abnormalities (Allegri, 
Mastromarino and Neri, 2010). Turmeric's main compo-
nent curcumin that is potent antioxidant substances like 
beta-carotene, vitamins E and C are used for cancer 
and liver diseases as well as an anti-ageing agent. Be-
sides, curcumin also eases back pain, arthritis, and 
bursitis by their anti-inflammatory property(Akramet al., 
2010). Three different properties of curcumin act to-
gether and responsible for the anti-inflammatory action: 
(i) curcumin reduces the production of inflammatory 
molecules such as histamine (ii) curcumin enhances 
the secretion of natural anti-inflammatory hormone 
(adrenal and cortisol) that increases the blood circula-
tion and eliminate the toxic substance from the body 
(III) research also confirmed that curcumin also pro-
motes the flow of bile juice by the gall bladder and final-
ly increases the digestion of fat and eliminate toxic/
waste materials outside the body (Akram et al., 2010). 
Curcumin's antioxidant and anti-inflammatory proper-
ties (Surh et al., 2001) minimize the lipid peroxidation 
and prevents cardiovascular diseases (Smerak et al., 
2006). 
Curcumin displays broad-spectrum therapeutic activi-
ties, but due to its low oral bioavailability, rapid degra-
dation, and poor water solubility, it could not make a 
clinical impact (Sharma et al., 2007).  Curcumin nano-
particles enhance bioavailability (Muqbil et al., 2011). It 
has been reported that particle size plays an important 
role in enhancing cellular uptake, absorption, physical 
stability, and drug release from the nano surface (Feng, 
2004). Different types of nanocarriers have been used 
in drug delivery systems like liposome, solid lipids nan-
ospheres, silicon or carbon as well as dendrimers, etc. 
(Karuppusamy and Venkatesan, 2017). PLGA is an 
important biodegradable polymer used in nanomedicine 
as a drug delivery vehicle, and hydrolysis results in the 
formation of glycolic acid and lactic acid, metabolized in 
Kreb's cycle and eliminated as CO2 and H2O from the 
body. PLGA is used as a drug delivery system in hu-
mans approved by the European Medicine Agency and 
US FDA (Mirakabad et al., 2014). Curcumin loaded 
PLGA nanoparticles exhibited schistosomicidal activity, 
at the concentration of 50 and 100 µM, 100 % death of 
parasites caused by these particles at 120 hrs (Luz et 
al., 2012). Yallapu et al., reported that curcumin loaded 
nanoparticles effective against ovarian cancer (Yallapu 
et al., 2010). Curcumin-nanoparticles inhibited first 
stage metastasis, hence can be used in the cancer 
treatment (Bisht et al., 2007). 
Conclusion 
In the present review article, we have explored the 
characteristics of curcumin, variety of functions, various 
nano-curcumin formulation methods, their pros and 
cons, and the importance of PLGA-nano curcumin 
against pathogenic bacteria. Curcumin is nontoxic and 
has great therapeutic roles like antimicrobial, antioxi-
dant, anti-inflammatory, anti-cancerous, anti-
cholesterol, and antidiabetic as well as shows hepa-
toprotective, neuronal protective, immune enhancer,  
cardiovascular and gastrointestinal effects. Curcumin 
nanoparticles have immense importance in thera-
peutics and can be used in combinatorial drug thera-
py such as (I) PLGA-curcumin-nanoparticles com-
bined with first-line antibiotics (amoxicillin, erythro-
mycin, etc) may be effective against multidrug-
resistant bacteria. (II) formulation of broad-spectrum 
antibiotic products that stop the growth of Gram-
positive and Gram-negative bacterial infections. (III) 
formulation of curcumin-based ointment or gel for 
wound healing and skin infections. Besides this, cur-
cumin may also be effective for crop productivity, 
and when mixed with soil, it increases the fertility of the 
soil. Curcumin's antioxidant property is the most im-
portant feature, which makes it more powerful as well 
as increases its therapeutic importance against life-
threatening illnesses like AIDS, cancer, tumor, cardi-
ovascular diseases, and lifestyle diseases such as 
diabetes. Almost all the aspects of curcumin, its role, 
and applications in therapeutics, emphasizing the 
antimicrobial properties against Gram-positive patho-
gens and the use of PLGA-curcumin nanoparticles in 
combinatorial drug therapy against resistant bacterial 
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strains which is the prominent necessity of the pre-
sent time, especially in developing countries have 
been discussed.  
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